Psychosocial Treatment for Improving Chances of Survival in Women With Breast Cancer

Stage IIIB, IV, Recurrent, and Metastatic Breast Cancer Clinical Trial

Official title:
Psychosocial Treatment Effects on Cancer Survival

Status Completed

Clinical Trial Summary

This study will investigate the influence of psychosocial treatment on psychological outcomes and survival among women with metastatic or recurrent breast cancer.

Clinical Trial Description

The objective of this study is to investigate the influence of psychosocial treatment on psychological outcomes and survival among women with metastatic/recurrent breast cancer. ;

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Stage IIIB, IV, Recurrent, and Metastatic Breast Cancer

Clinical Trial Details

NCT number	NCT00226928
Study type	Interventional
Source	Stanford University
Contact
Status	Completed
Phase	N/A
Completion date	July 2005

View Details

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT02030678` - A Phase II Study of Irinotecan in 3 Line or More Therapy in Local Recurrence or Metastatic Breast Cancer	Phase 2
	Recruiting	`NCT02188693` - Gemcitabine as a Single Agent in the Maintenance Chemotherapy of Patients With Metastatic Breast Cancer	N/A